Clinical Trials on Neurofibromatóza typu 2

Total 57485 results

Riphah International University

Completed

The Effects of Pilates on Functional Capacity and Blood Glucose Levels in Adults With Diabetes Type 2

Type 2 Diabetes Mellitus

Pakistan
Sanofi

Completed

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes (LixiLan-India)

Type 2 Diabetes Mellitus

India
Sanofi

Completed

Comparison of Two Treatment Regimens in Patients With Type 2 Diabetes After Short-term Intensive Insulin Therapy (SWITCH)

Type 2 Diabetes Mellitus

China
Sanofi

Completed

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period (LixiLan-G)

Type 2 Diabetes Mellitus

Estonia, Italy, Israel, United States, Canada, Germany, Romania, Slovakia, Spain
Universidad de Guanajuato

Completed

Insulin Schemes for Type 2 Diabetes Control

Type 2 Diabetes Mellitus

Mexico
Eli Lilly and Company

Completed

A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone (SURPASS-1)

Type 2 Diabetes Mellitus

United States, Japan, India, Puerto Rico, Mexico
Merck Sharp & Dohme LLC

Completed

A Study to Assess the Pharmacokinetics and the Ability for Pediatric Participants With Type 2 Diabetes to Swallow MK-0431A XR Tablets (MK-0431A-296)

Type 2 Diabetes Mellitus
Hospital de Clinicas de Porto Alegre

Completed

Improvement of Care for Outpatients With Type 2 Diabetes Through Self-Care Multidisciplinary Workshop for Diabetes

Type 2 Diabetes Mellitus

Brazil
Population Health Research Institute
Hamilton Health Sciences Corporation

Completed

Remission Evaluation of Metabolic Interventions in Type 2 Diabetes (REMIT Pilot Trial)

Type 2 Diabetes Mellitus

Canada
University of Pretoria
South African Sugar Association

Completed

Nutrition Education Intervention for Adults With Type 2 Diabetes

Type 2 Diabetes Mellitus

South Africa
Catholic Kwandong University

Completed

Abnormal Blood Sugar Tests in Diabetic Patients During Colonoscopy Preparation

Type 2 Diabetes Mellitus | Colonoscopy

Korea, Republic of
University of Alberta

Completed

Does Exercise Timing Affect Glucose Levels in People With Diabetes?

Type 2 Diabetes Mellitus

Canada
Novo Nordisk A/S

Completed

Comparing Efficacy and Safety of Thrice Daily Versus Twice Daily NovoMix® 30 (Biphasic Insulin Aspart 30) in Subjects With Type 2 Diabetes Inadequately Controlled With Basal Insulin

Diabetes | Type 2 Diabetes Mellitus

Taiwan, Turkey, India, Algeria, Hong Kong, China, Ukraine
Mitsubishi Tanabe Pharma Corporation

Completed

Confirmatory Study of MT-2412 in Japanese Patients With Type 2 Diabetes (Add-on Study of Canagliflozin)

Type 2 Diabetes Mellitus

Japan
Samsung Medical Center
Novartis

Completed

The Effect of Vildagliptin Based Treatment Versus Sulfonylurea on Glycemic Variability, Oxidative Stress, GLP-1, and Endothelial Function in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

Korea, Republic of
Duke-NUS Graduate Medical School
SingHealth Polyclinics

Completed

A Single Arm Feasibility Study of GlycoLeap, an On-line Lifestyle Modification and Self-management Program for People With Type 2 Diabetes

Type 2 Diabetes Mellitus

Singapore
AstraZeneca Turkey
Optimum Contract Research Organization, Turkey

Completed

Dapagliflozin in Type 2 Diabetes Patients, a Retrospective Cohort Study From Turkey (DAPA-TURK)

Type 2 Diabetes Mellitus

Turkey
Cheng Qing-feng

Unknown

Effect of Holistic Management on the Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus
Merete Bechmann Christensen
Novo Nordisk A/S

Unknown

Basal-bolus Insulin Therapy Versus Standard Therapy for the Inpatient Management of Type 2 Diabetes: the IDA2 Study

Type 2 Diabetes Mellitus

Denmark
Sun Yat-sen University

Unknown

Impacts of PIO/MET Following Short-term Intensive Insulin Treatment in Newly Diagnosed Type 2 Diabetes

Type 2 Diabetes Mellitus

China
First Affiliated Hospital Xi'an Jiaotong University

Unknown

Therapies on Newly Diagnosed Type 2 Diabetes Patients With High Glucose Toxicity Which Protect Islet β Cell (TOND)

Type 2 Diabetes Mellitus

China
AstraZeneca
Astra Zeneca, Bristol-Myers Squibb

Completed

Effects of Dapagliflozin on Kidney Function (Glomerular Filtration Rate) in Subjects With Type 2 Diabetes

Type 2 Diabetes Mellitus

United States, Netherlands, Canada
Lawson Health Research Institute
AstraZeneca

Completed

Health Outcomes of Patients With Type 2 Diabetes Treated With Dapagliflozin in Conjunction With Insulin

Type 2 Diabetes Mellitus
University of Palermo
AstraZeneca

Completed

Exenatide Once Weekly, Cardiovascular Risk and Type-2 Diabetes

Type 2 Diabetes Mellitus

Italy
Dong-A ST Co., Ltd.

Completed

Efficacy and Safety of Evogliptin add-on to Metformin in Patients With type2 Diabetes

Type 2 Diabetes Mellitus

Korea, Republic of
Novartis Pharmaceuticals

Completed

Vildagliptin/Metformin in T2DM Patients Starting Basal Insulin (ADDONIS)

Type 2 Diabetes Mellitus (T2DM)

France
Fifth Affiliated Hospital, Sun Yat-Sen University

Unknown

Safety and Efficacy of Acarbose+Saxagliptin Compared With Metformin+Saxagliptin in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC

Terminated

A Single-Dose Study of MK6349 in Patients With Type 2 Diabetes (6349-002)

Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC

Completed

Safety/Efficacy of Sitagliptin in Patient w/ Type 2 Diabetes (0431-801)

Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC

Completed

An Investigational Drug Study in Adults With Type 2 Diabetes on Basal Insulin (MK-0941-006)

Type 2 Diabetes Mellitus
AstraZeneca
Eli Lilly and Company

Completed

Efficacy of Exenatide Once Weekly and Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Treated With Metformin Alone or in Combination With Sulfonylurea (DURATION - 3)

Type 2 Diabetes Mellitus

United States, Czech Republic, France, Korea, Republic of, Russian Federation, Spain, Mexico, Australia, Belgium, Denmark, Germany, Hungary, Netherlands, Puerto Rico, Greece, Taiwan
Valeritas, Inc.
Integrated Medical Development

Completed

Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting (SIMPLE)

Type 2 Diabetes Mellitus

United States
Sanofi

Completed

Safety And Tolerability Of Lixisenatide In Monotherapy In Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

Japan
AstraZeneca
Eli Lilly and Company

Completed

CHOICE: CHanges to Treatment and Outcomes in Patients With Type 2 Diabetes Initiating InjeCtablE Therapy

Type 2 Diabetes Mellitus

Sweden, Germany, Greece, Denmark, France
AstraZeneca
Eli Lilly and Company

Completed

Safety and Efficacy of Exenatide Once Weekly Versus Liraglutide in Subjects With Type 2 Diabetes

Type 2 Diabetes Mellitus

Australia, France, Italy, Korea, Republic of, Mexico, Spain, Poland, Romania, South Africa, Argentina, Austria, Belgium, Germany, Hungary, Israel, Slovakia, Greece, India, Taiwan, Canada, Czech Republic
AstraZeneca
Eli Lilly and Company

Completed

A Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 Diabetes

Type 2 Diabetes Mellitus

Sweden, Italy, Korea, Republic of, Mexico, Russian Federation, Spain, Estonia, Romania, Finland, Netherlands, Argentina, Belgium, Germany, Portugal, United Kingdom, Greece, France, Puerto Rico
AstraZeneca
Eli Lilly and Company

Completed

Efficacy of Once-Weekly Exenatide Versus Once or Twice Daily Insulin Detemir in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

Ireland, United Kingdom
AstraZeneca
Eli Lilly and Company

Completed

Effects of Exenatide and Insulin Glargine in Subjects With Type 2 Diabetes

Type 2 Diabetes Mellitus

Finland, Netherlands, Sweden
AstraZeneca
Eli Lilly and Company

Completed

A Study to Assess the Effect on Glucose Control and Safety and Tolerability of LY2148568 In Japanese Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

Japan
KU Leuven

Completed

Telecoaching of People With Type 2 Diabetes in Primary Care

Type 2 Diabetes Mellitus | Telenursing
Endocrine Research Society

Completed

Evaluation of Iphone Technology in Diabetes Treatment

Type 2 Diabetes Mellitus

Canada
Endocrine Research Society

Completed

Blood Monitoring and Data Acquisition and Utilization in Patients With Type 2 Diabetes Treated With Insulin

Type 2 Diabetes Mellitus

Canada
University of Manitoba
Manitoba Institute of Child Health

Completed

Lifestyle Therapy for Youth With Type 2 Diabetes (BDT)

Type 2 Diabetes Mellitus

Canada
Sanofi

Completed

Efficacy and Safety of Insuman Basal/Comb/Rapid in Patients With Type 2 Diabetes (SPIRIT)

Type 2 Diabetes Mellitus

Ukraine
Sanofi

Completed

Evaluation of Fixed Dose Combination of Glimepiride and Metformin in Chinese Type 2 Diabetes Patients Inadequately Controlled With Metformin

Type 2 Diabetes Mellitus

China
Rocky Mountain Diabetes and Osteoporosis Center

Completed

Continuous Glucose Monitoring (CGM) in Subjects With Type 2 Diabetes (DexlonT2)

Type 2 Diabetes Mellitus

United States
Tehran University of Medical Sciences

Completed

Metformin and Pioglitazone Effects on Fetuin-A and Osteoprotegrin Concentrations in Type 2 Diabetes Patients

Type 2 Diabetes Mellitus

Iran, Islamic Republic of
Pfizer

Completed

A Multiple Dose Study Of PF-04620110 In Type 2 Diabetes Patients

Type 2 Diabetes Patients

United States
LG Life Sciences

Completed

Phase 3 Trial to Evaluate the Efficacy and Safety of LC15-0444 in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

Korea, Republic of
Maastricht University Medical Center

Completed

Vinegar Co-ingestion in Type 2 Diabetes

Type 2 Diabetes Mellitus

Netherlands

3

Subscribe